OpenResearchAlpha

bioRxiv · 5 Nov 2026

Clinical-Anchored Incremental Survival Learning: A Stability-Constrained Framework for Molecularly Enhanced Survival Prediction in Lung Adenocarcinoma

Parth Shringarpure, Sonica Divakar, Shrutika Khobragade

0
Citations
no database records one yet
0
Citations in 2026
so far
–
Leading author's h-index
no author has a profile yet
0
References
works it cites, from open citation data

Citations by database

Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.

  • OpenCitations0
  • Crossref0

Citations per year

The current year is still counting.

  • 2026 so far0

Abstract

Accurate survival prediction in lung adenocarcinoma (LUAD) remains challenging because high-dimensional molecular data can introduce overfitting and unstable feature selection. We developed Clinical-Anchored Incremental Survival Learning (CAISL), a framework that integrates a sparse molecular risk correction with a clinical baseline to improve prognostic discrimination while constraining model complexity and prediction variability. CAISL was evaluated using The Cancer Genome Atlas LUAD cohort comprising 470 patients and 119 observed deaths. Performance was compared with clinical Cox, molecular-only, and unanchored multimodal models using five independently seeded, event-stratified five-fold cross-validation runs. CAISL achieved a mean concordance index (C-index) of 0.7246, compared with 0.6970 for clinical Cox, yielding an absolute improvement of 0.0276 (95% bootstrap confidence interval [CI], 0.005 to 0.050). Time-dependent discrimination was higher at three years (AUC, 0.742 vs. 0.712) and five years (AUC, 0.721 vs. 0.691), while the integrated Brier score was lower for CAISL than for clinical Cox (0.164 vs. 0.181). Ablation analysis identified clinical anchoring as the component associated with the largest reduction in discrimination when removed. Stability analysis showed a mean pairwise Jaccard similarity of 0.46 between selected feature sets and a mean Spearman correlation of 0.86 between molecular correction scores. These findings support the potential of clinically anchored, stability-constrained molecular learning to improve internal survival-risk prediction in LUAD. Independent-cohort validation is needed to establish generalizability.

Bioinformatics

What the data shows

  • No database records a citation yet, as is usual for a paper this new.

Graph

This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.

Citing paper shares an authorAuthor without a profileSize shows citations, or h-index for authors

Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.

Start with

Authors (3)

Each author's standing in QAI's scholar index: the works their ORCID iD is attached to, and for anyone whose ORCID record names a lab OpenResearch follows, their arXiv preprints matched by name and a shared co-author. Names are as printed on the paper.

ProfileMost-cited paper

Cited by 0 papers

Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.

0 shown
No citing papers for this filter.

References (0)

What it cites, from open citation data, with Crossref's record of each.

No references in the open citation data yet.
Clinical-Anchored Incremental Survival Learning: A Stability-Constrained Framework for Molecularly Enhanced Survival Prediction in Lung Adenocarcinoma - QAI OpenResearch